$GNID **Please Read** Guaranteed Nasdaq Up List
Post# of 225
Posted On: 09/29/2016 11:35:48 PM
$GNID **Please Read**
Guaranteed Nasdaq Up List Before Year's End, that's $4.00 minimum
How?
Wellington Shield's is underwriting a $40,000,000 CMPO Offering
A CMPO Offering does not require a Reverse Split.
Blue Chip Investment Banker Wellington Shield's and GNID agreed to remove debt utilizing non toxic financing of up to $1,000,000, plus set aside a $15,000,000 facility to acquire multiple companies with Revenues/Profits and EBITDA. This will change the Enterprise Value of GNID to approx. $25,000,000 and Wellington Shield's will then utilize their professional analyst to evaluate GNID and issue a NEW PPS. (Total Agreement valued @ $56,000,000, ALL Agreements in Q1)
No S-1 required, No Reverse Split required
A CMPO can be accomplished in 3 days with no one knowing when, go to bed at $0.50 or what ever it closes at and wake up the day of the CMPO at a minimum of $4.00 on the NASDAQ with HUGE Wallstreet backing.
All IN PLACE by END of Q3
Current Float Approx. 3,000,000 with total Outstanding approx. 16,000,000 and 85-90% RESTRICTED.
The best part is there's approx. 2,000,000 Shares Short. Remember what happened to KBIO, this is much bigger.
So look for Multiple 8-Ks confirming the Toxic Debt paid in full and Multiple Acquisitions ALL before the End of Q3.
From today's PPS you are looking at 4,000% but GNID will most likely trade at or above $10.00 when the CMPO goes through.
So $40,000,000 CMPO minus $15m Facility = $25m - $1m Debt Removal = $24m CASH ON HAND PLUS Multiple Revenue Stream from the Newly Acquired Companies.
Huge Christmas for Real Investors, TIMES RUNNING OUT
TERMS of the $56,000,000, 3 TIER AGREEMENT(Q1)>> On May 12, 2016 the Company entered into three agreements with Wellington Shields and Co, LLC, the Company’s new investment banker.
In the first agreement, the Company engaged and retained Wellington Shields as its financial advisor as it relates to a private placement of up to $1,000,000, terminating at the close of business October 31, 2016. In consideration for the services rendered by Wellington Shields the Company agrees to pay a placement success fee equal to 10% of the gross proceeds and a warrant to purchase common shares of the Company equal to 4% of the amount of the placement at a purchase price equal to 110% of the implied price per share of the placement.
In the second agreement the Company engaged and retained Wellington Shields as a placement agent to Rx Safes, Inc as it relates to acquisition financing of up to $15,000,000, terminating at the close of business December 1, 2016. In consideration for the services rendered by Wellington Shields, the Company agrees to pay placement success fee equal to 8% of the gross proceeds of the placement, common shares equal to 3% of the outstanding shares of Rx Safes, Inc. post closing and a monthly accruing retainer of $10,000 per month, payable at the time of a financing at any amount of $5 million.
In the third agreement the Company engaged and retained Wellington Shields as its Exclusive Investment Banker for a twelve-month term as it relates to a Public Offering of up to $40,000,000 on a national exchange. In consideration for the services rendered by Wellington Shields the Company agrees to pay offering commission equal to 6% of the gross proceeds of the sale of the Company’s shares and offering warrants equal to 3% of the amounts raised at a purchase price equal to 110% of the implied price per share of the sale or 110% of the public market closing price of the Company’s common stock on the date of the sale, whichever is lower.
Guaranteed Nasdaq Up List Before Year's End, that's $4.00 minimum
How?
Wellington Shield's is underwriting a $40,000,000 CMPO Offering
A CMPO Offering does not require a Reverse Split.
Blue Chip Investment Banker Wellington Shield's and GNID agreed to remove debt utilizing non toxic financing of up to $1,000,000, plus set aside a $15,000,000 facility to acquire multiple companies with Revenues/Profits and EBITDA. This will change the Enterprise Value of GNID to approx. $25,000,000 and Wellington Shield's will then utilize their professional analyst to evaluate GNID and issue a NEW PPS. (Total Agreement valued @ $56,000,000, ALL Agreements in Q1)
No S-1 required, No Reverse Split required
A CMPO can be accomplished in 3 days with no one knowing when, go to bed at $0.50 or what ever it closes at and wake up the day of the CMPO at a minimum of $4.00 on the NASDAQ with HUGE Wallstreet backing.
All IN PLACE by END of Q3
Current Float Approx. 3,000,000 with total Outstanding approx. 16,000,000 and 85-90% RESTRICTED.
The best part is there's approx. 2,000,000 Shares Short. Remember what happened to KBIO, this is much bigger.
So look for Multiple 8-Ks confirming the Toxic Debt paid in full and Multiple Acquisitions ALL before the End of Q3.
From today's PPS you are looking at 4,000% but GNID will most likely trade at or above $10.00 when the CMPO goes through.
So $40,000,000 CMPO minus $15m Facility = $25m - $1m Debt Removal = $24m CASH ON HAND PLUS Multiple Revenue Stream from the Newly Acquired Companies.
Huge Christmas for Real Investors, TIMES RUNNING OUT
TERMS of the $56,000,000, 3 TIER AGREEMENT(Q1)>> On May 12, 2016 the Company entered into three agreements with Wellington Shields and Co, LLC, the Company’s new investment banker.
In the first agreement, the Company engaged and retained Wellington Shields as its financial advisor as it relates to a private placement of up to $1,000,000, terminating at the close of business October 31, 2016. In consideration for the services rendered by Wellington Shields the Company agrees to pay a placement success fee equal to 10% of the gross proceeds and a warrant to purchase common shares of the Company equal to 4% of the amount of the placement at a purchase price equal to 110% of the implied price per share of the placement.
In the second agreement the Company engaged and retained Wellington Shields as a placement agent to Rx Safes, Inc as it relates to acquisition financing of up to $15,000,000, terminating at the close of business December 1, 2016. In consideration for the services rendered by Wellington Shields, the Company agrees to pay placement success fee equal to 8% of the gross proceeds of the placement, common shares equal to 3% of the outstanding shares of Rx Safes, Inc. post closing and a monthly accruing retainer of $10,000 per month, payable at the time of a financing at any amount of $5 million.
In the third agreement the Company engaged and retained Wellington Shields as its Exclusive Investment Banker for a twelve-month term as it relates to a Public Offering of up to $40,000,000 on a national exchange. In consideration for the services rendered by Wellington Shields the Company agrees to pay offering commission equal to 6% of the gross proceeds of the sale of the Company’s shares and offering warrants equal to 3% of the amounts raised at a purchase price equal to 110% of the implied price per share of the sale or 110% of the public market closing price of the Company’s common stock on the date of the sale, whichever is lower.
(0)
(0)GeneSYS ID, Inc. (GNID) Stock Research Links
Scroll down for more posts ▼